Cargando…

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

The concept of diabetic retinopathy as a microvascular disease has evolved and is now considered a more complex diabetic complication in which neurovascular unit impairment plays an essential role and, therefore, can be considered as a main therapeutic target in the early stages of the disease. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simó, Rafael, Simó-Servat, Olga, Bogdanov, Patricia, Hernández, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399715/ https://www.ncbi.nlm.nih.gov/pubmed/34452281 http://dx.doi.org/10.3390/pharmaceutics13081320

Ejemplares similares

Genetics in Diabetic Retinopathy: Current Concepts and New Insights
por: Simó-Servat, Olga, et al.
Publicado: (2013)

New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2022)

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
por: Simó-Servat, Olga, et al.
Publicado: (2016)

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
por: Simó-Servat, Olga, et al.
Publicado: (2012)

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy
por: Sampedro, Joel, et al.
Publicado: (2019)

Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
por: Bogdanov, Patricia, et al.
Publicado: (2022)

Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy
por: Ramos, Hugo, et al.
Publicado: (2022)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
por: Simó, Rafael, et al.
Publicado: (2021)

Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy
por: Ramos, Hugo, et al.
Publicado: (2021)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)

Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes
por: Hernández, Cristina, et al.
Publicado: (2020)

Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications
por: Ramos, Hugo, et al.
Publicado: (2023)

Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
por: Planas, Alejandra, et al.
Publicado: (2022)

Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases
por: Sundstrom, Jeffrey M., et al.
Publicado: (2018)

Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients
por: Planas, Alejandra, et al.
Publicado: (2021)

Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy
por: Valverde, Angela M., et al.
Publicado: (2013)

Advances in the Medical Treatment of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2009)

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
por: Hernández, Cristina, et al.
Publicado: (2016)

Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy
por: Ramos, Hugo, et al.
Publicado: (2022)

Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia
por: Simó-Servat, Olga, et al.
Publicado: (2019)

Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2019)

What else can we do to prevent diabetic retinopathy?
por: Simó, Rafael, et al.
Publicado: (2023)

State-of-the-Art Research on Diabetic Retinopathy
por: Simó, Rafael
Publicado: (2022)

Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets
por: Nian, Shen, et al.
Publicado: (2021)

Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?
por: Ciudin, Andreea, et al.
Publicado: (2010)

Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy
por: Meng, Chunren, et al.
Publicado: (2021)

Autophagy in the retinal neurovascular unit: New perspectives into diabetic retinopathy
por: Yang, Xiongyi, et al.
Publicado: (2023)

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study
por: Simó, Rafael, et al.
Publicado: (2019)

Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration
por: Simó, Rafael, et al.
Publicado: (2023)

Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish
por: Middel, Chiara Simone, et al.
Publicado: (2021)

Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study
por: Ciudin, Andreea, et al.
Publicado: (2019)

Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel, et al.
Publicado: (2023)

The Gaze Fixation Assessed by Microperimetry: A Useful Tool for the Monitoring of the Cognitive Function in Patients with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel Michael, et al.
Publicado: (2021)

Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy
por: Qian, Haohua, et al.
Publicado: (2011)

Neurodegeneration in diabetic retinopathy: does it really matter?
por: Simó, Rafael, et al.
Publicado: (2018)

Beneficial Effects of Glucagon-Like Peptide-1 (GLP-1) in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress
por: Ramos, Hugo, et al.
Publicado: (2020)

The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial
por: Hernández, Cristina, et al.
Publicado: (2020)

Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies
por: Alcubierre, Nuria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rhu4g37tlvaqfl4m2234uhoa3q